Calmodulin-dependent kinase II mediates vascular smooth muscle cell proliferation and is potentiated by extracellular signal regulated kinase.
Vascular smooth muscle cell (VSMC) proliferation contributes to vascular remodeling in atherosclerosis and hypertension. Calcium-dependent signaling through calcium/calmodulin-dependent kinase II (CaMKII) and ERK1/2 activation plays an important role in the regulation of VSMC proliferation by agents such as alpha-adrenergic receptor agonists. Nevertheless, how the CaMKII and ERK pathways interact in VSMCs has yet to be characterized. The aim of the present study was to clarify this interaction in response to alpha(1)-adrenergic receptor-mediated VSMC proliferation. We discovered that phenylephrine stimulation resulted in complex formation between CaMKII and ERK in a manner that facilitated phosphorylation of both protein kinases. To assess the effects of CaMKII/ERK association on VSMC proliferation, we inhibited endogenous CaMKII either pharmacologically or by adenoviral-mediated gene transfer of a kinase-inactive CaMKII mutant. Inhibition of CaMKII activation but not CaMKII autonomous activity significantly decreased formation of the CaMKII/ERK complex. On the contrary, the expression of constitutively active CaMKII enhanced VSMC growth and CaMKII/ERK association. In addressing the mechanism of this effect, we found that CaMKII could not directly phosphorylate ERK but instead enhanced Raf1 activation. By contrast, ERK interaction with CaMKII facilitated CaMKII phosphorylation and promoted its nuclear localization. Our results reveal a critical role for CaMKII in VSMC proliferation and imply that CaMKII facilitates assembly of the Raf/MEK/ERK complex and that ERK enhances CaMKII activation and influences its subcellular localization.
Cipolletta
E
E
Department of Biologia e Patologia Cellulare e Molecolare, via S. Pansini 5, 80131 Napoli, Italia.
Monaco
S
S
Maione
A S
AS
Vitiello
L
L
Campiglia
P
P
Pastore
L
L
Franchini
C
C
Novellino
E
E
Limongelli
V
V
Bayer
K U
KU
Means
A R
AR
Rossi
G
G
Trimarco
B
B
Iaccarino
G
G
Illario
M
M
D058646:Adrenergic alpha-1 Receptor Agonists; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2 / Q000378:metabolism*; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism*; D006801:Humans; D015151:Immunoblotting; D047468:Immunoprecipitation; D018613:Microscopy, Confocal; D009131:Muscle, Smooth, Vascular / Q000166:cytology*; D032389:Myocytes, Smooth Muscle / Q000187:drug effects / Q000378:metabolism*; D010656:Phenylephrine / Q000494:pharmacology; D010766:Phosphorylation / Q000187:drug effects; D011485:Protein Binding / Q000187:drug effects; D018340:Receptors, Adrenergic, alpha-1 / Q000235:genetics / Q000378:metabolism*
D058646:Adrenergic alpha-1 Receptor Agonists; D004791:Enzyme Inhibitors; D018340:Receptors, Adrenergic, alpha-1; D010656:Phenylephrine; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D048049:Extracellular Signal-Regulated MAP Kinases
Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L43-54
12788788
FEBS Lett. 2002 Apr 24;517(1-3):206-10
12062438
J Biol Chem. 1999 May 14;274(20):13978-84
10318809
Trends Biochem Sci. 1999 Jun;24(6):232-6
10366852
J Pharmacol Exp Ther. 1999 Jul;290(1):28-37
10381756
Am J Physiol Cell Physiol. 2002 Apr;282(4):C754-61
11880263
Am J Physiol Cell Physiol. 2005 Nov;289(5):C1343-50
15944210
N Engl J Med. 2003 Oct 2;349(14):1307-9
14523135
Nat Rev Mol Cell Biol. 2003 Jul;4(7):517-29
12838335
J Biochem. 2001 Feb;129(2):193-9
11173518
Circ Res. 1997 Oct;81(4):575-84
9314839
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10890-5
9724800
J Biol Chem. 2003 Nov 14;278(46):45101-8
12954639
Mol Pharmacol. 1997 May;51(5):764-75
9145914
Trends Cardiovasc Med. 2003 May;13(4):142-8
12732447
Neuron. 1998 Sep;21(3):593-606
9768845
Atherosclerosis. 1995 Dec;118 Suppl:S125-40
8821472
N Engl J Med. 2003 Oct 2;349(14):1315-23
14523139
Nature. 1995 Aug 31;376(6543):781-4
7651538
Annu Rev Pharmacol Toxicol. 2001;41:471-505
11264466
Am J Physiol Cell Physiol. 2007 Jun;292(6):C2276-87
17267544
J Biol Chem. 1996 Nov 22;271(47):30149-57
8939965
J Biol Chem. 1995 Dec 29;270(52):30980-8
8537355
Mol Endocrinol. 2005 Sep;19(9):2412-23
15890671
J Clin Endocrinol Metab. 2005 May;90(5):2865-73
15687337
N Engl J Med. 1999 Jan 14;340(2):115-26
9887164
J Biol Chem. 1996 Feb 2;271(5):2506-13
8576214
Annu Rev Physiol. 1995;57:791-804
7778883
Cell Res. 2008 Apr;18(4):436-42
18347614
J Biol Chem. 2001 Nov 9;276(45):42514-9
11535587